According to the Zhitong Finance APP, haohai biotec (06826) announced that due to the company's repurchase and cancellation of some H-shares, attributing A-share stock-based incentives, and the capital reserve fund conversion leading to changes in the company's total share capital, resulting in the controlling shareholder, the actual controller Mr. Jiang Wei, Ms. You Jie, and their concerted action person Shanghai Zhanze Enterprise Management Partnership Enterprise (limited partnership) (hereinafter referred to as "Shanghai Zhanze") jointly holding a stake ratio change from 45.53% to 46.62%, an accumulated increase of 1.09% in shareholding ratio.